UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	November 13, 2023 4:00 P.M.

Form:	S-4
CIK: 0001404644 Company Name: Neoleukin Therapeutics, Inc. File Number: 333-274095